Like prostate cancer, bladder cancer patients may benefit from anti-androgen therapy
Monday, September 24, 2012 - 20:00
in Health & Medicine
Bladder cancer patients whose tumors express high levels of the protein CD24 have worse prognoses than patients with lower CD24. A new study shows that CD24 expression may depend on androgens – and that anti-androgen therapies like those currently used to treat prostate cancer may benefit bladder cancer patients.